Family Physician attitudes about prescribing using a drug formulary

BMC Family Practice

Volumn 10, Issue , 2009, Pages

  Suggs, L Suzanne ^a   Raina, Parminder ^b   Gafni, Amiram ^b   Grant, Susan ^c   Skilton, Kevin ^c   Fan, Aimei ^d   Szala Meneok, Karen ^b  

^a UNIVERSITY OF LUGANO   (Switzerland)

^b MCMASTER UNIVERSITY   (Canada)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d Public Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TERBUTALINE;

ADULT; AGED; ARTICLE; ASTHMA; CANADA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMPUTER PROGRAM; COST BENEFIT ANALYSIS; DIET THERAPY; DRUG EFFICACY; DRUG FORMULARY; DRUG SAFETY; DRUG USE; EXERCISE; FEMALE; GENERAL PRACTITIONER; HEALTH SCIENCE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MALE; MEDICAL ETHICS; MEDICINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN ENDED QUESTIONNAIRE; OSTEOARTHRITIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT ADVOCACY; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; REIMBURSEMENT; UNIVERSITY; COMPARATIVE STUDY; COST CONTROL; DRUG COST; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH PERSONNEL ATTITUDE; LEGAL ASPECT; METHODOLOGY; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; PUBLICATION; QUESTIONNAIRE; STANDARD; STATISTICS;

AGED; ATTITUDE OF HEALTH PERSONNEL; CANADA; COST CONTROL; DRUG COSTS; DRUG PRESCRIPTIONS; FEMALE; FOCUS GROUPS; FORMULARIES AS TOPIC; GUIDELINES AS TOPIC; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; NATIONAL HEALTH PROGRAMS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PHYSICIANS, FAMILY; QUESTIONNAIRES; REIMBURSEMENT MECHANISMS;

EID: 70450248548     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-10-69     Document Type: Article

References (27)

1. The new medicare drug benefit: formularies and their potential effects on access to medications. HA Huskamp NL Keating, J Gen Intern Med 2005 20 662 665 10.1007/s11606-005-0115-3 16050866
2. Physicians' views of formularies: implications for Medicare drug benefit design. BE Landon JD Reschovsky D Blumenthal, Health Aff (Millwood) 2004 23 218 226 10.1377/hlthaff.23.1.218 15002646
3. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. SG Morgan JD Agnew ML Barer, Health Policy 2004 68 299 307 10.1016/j.healthpol.2003.10.006 15113641
4. Whither seniors' pharmacare: lessons from (and for) Canada. SG Morgan ML Barer JD Agnew, Health Aff (Millwood) 2003 22 49 59 10.1377/hlthaff.22.3.49 12757272
5. The impact of pharmacotherapy policy: a case study. R Tamblyn, Can J Clin Pharmacol 2001 8 Suppl A 39A 44A 11586378
6. How the reimbursement system may influence physicians' decisions results from focus groups interviews in France. C Huttin J Andral, Health Policy 2000 54 67 86 10.1016/S0168-8510(00)00101-9 11094264
7. Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues? AJ Avery RV Wetzels S Rodgers C O'Neill, Br J Gen Pract 2000 50 100 104 10750205
8. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. S Schneeweiss SB Soumerai RJ Glynn M Maclure C Dormuth AM Walker, CMAJ 2002 166 737 745 11944760
9. Ontario Drug Benefit Formulary/Comparative Drug Index No. 38. Ontario Ministry of Health and Long Term Care, Ontario Drug Benefit Program. Ontario Drug Benefit Program No. 38. 1-30-2003 Ontario Ministry of Health and Long Term Care. 1-6-2009 http://www.health.gov.on.ca/english/providers/program/drugs/ formulary-38/ed38-0-bk.pdf
10. The Government's Plan to Reform Ontario's Drug System. Ontario Ministry of Health and Long Term Care & Ontario Drug Benefit Program, Ontario Ministry of Health and Long Term Care 2006 http://www.health.gov.on.ca/english/ providers/program/drugs/plan-reform-ods/plan-reform-ods.html
11. Ontario Drug Benefit Formulary/Comparative Drug Index (Formulary) Limited Use Modernization Strategy. Ontario Ministry of Health and Long Term Care & Ontario Drug Benefit Program, 2006 1 9 http://www.health.gov.on.ca/english/ providers/program/drugs/odbf/intervent-092705-faq.pdf
12. Effects of restrictive formularies in the ambulatory care setting. J Lexchin, Am J Manag Care 2002 8 69 76 11814174
13. RA Krueger MA Casey, Focus Groups: A Practical Guide for Applied Research Thousand Oaks, Califorina: Sage Publications 3 2000
14. Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario. PS Raina A Gafni S Bell S Grant RJ Sebaldt A Fan A Petrie K Skilton, Healthc Policy 2007 3 128 e144 19305773
15. Barriers to patient-physician communication about out-of-pocket costs. GC Alexander LP Casalino CW Tseng D McFadden DO Meltzer, Journal of General Internal Medicine 2004 19 856 860 10.1111/j.1525-1497.2004.30249.x 15242471
16. Patient-physician communication about out-of-pocket costs. GC Alexander LP Casalino DO Meltzer, Jama-Journal of the American Medical Association 2003 290 953 958 10.1001/jama.290.7.953 (Pubitemid 37430470)
17. Health Care in Canada Survey 2005: A National Survey of Health Care Providers, Managers, and the Public. Pollara Research, Internet 2005 http://www.mediresource.com/e/pages/hcc-survey/pdf/2005-hcic.pdf 4-2-0006.
18. Primary care: core values. Core values in a changing world. IR McWhinney, BMJ 1998 316 1807 1809 10.1056/NEJMp058248 9624075
19. Ontario Drug Benefit Formulary/Comparative Drug Index Edition 39. Ontario Ministry of Health and Long Term Care, Ontario Drug Benefit Program, 2005 19 20 http://www.health.gov.on.ca/english/providers/program/drugs/formulary/ed39-0- bk.pdf
20. Implementation Strategies: Too Many Hours, Too Much Stress, Too Little Respect. MJL Kasperski, Toronto, Ontario College of Family Physicians 2000 http://www.ocfp.on.ca/English/OCFP/Communications/Publications/
21. Promise and perils for patients and physicians. RL Kravitz S Chang, New England Journal of Medicine 2005 353 2735 2739 16382057
22. Ontario Medical Association Response to the Drug Strategy Review: June 2003. Ontario Medical Association, Internet 2006 http://www.oma.org/phealth/ 03DSRresponse.htm 5-5-0006. 10.1097/00005650-200104000-00003
23. Right Drug, Right Person, Right Price: Improving and Governing the Provincial Drug System. Ontario Ministry of Health and Long-Term Care Drug System Secretariat, Ontario Ministry of Health and Long-Term Care Drug 2006 http://www.health.gov.on.ca/english/public/legislation/drugs/ drugsact-stakeholder.pdf 1-6-2009.
24. Do family physicians know the costs of medical care? Survey in British Columbia. GM Allan GD Innes, Can Fam Physician 2004 50 263 270 10.1097/01.mlr.0000170002.90751.1a 15000338
25. A dog's breakfast: prescription drug coverage varies widely across Canada. AH Anis D Guh X Wang, Med Care 2001 39 315 326 10.1371/journal.pmed. 0040283 11329519
26. Incorporating economic evaluations into decision-making: the Ontario experience. A Laupacis, Med Care 2005 43 15 19 16056004
27. Physician awareness of drug cost: a systematic review. GM Allan J Lexchin N Wiebe, PLoS Med 2007 4 283 17896856